English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/129305
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Coenzyme Q10 therapy

AuthorsGarrido-Maraver, Juan; Cordero, Mario D. ; Oropesa-Ávila, Manuel; Fernández-Vega, Alejandro; Mata, Mario de la ; Delgado Pavón, Ana; Miguel, Manuel de; Pérez Calero, Carmen; Villanueva Paz, Marina; Cotán, David ; Sánchez-Alcázar, José Antonio
KeywordsCoenzyme Q10-related compounds
Clinical indications
Coenzyme Q10
Issue Date2014
PublisherS. Karger AG
CitationMolecular Syndromology 5(3-4): 187-197 (2014)
AbstractFor a number of years, coenzyme Q10 (CoQ10) was known for its key role in mitochondrial bioenergetics; later studies demonstrated its presence in other subcellular fractions and in blood plasma, and extensively investigated its antioxidant role. These 2 functions constitute the basis for supporting the clinical use of CoQ10. Also, at the inner mitochondrial membrane level, CoQ10 is recognized as an obligatory cofactor for the function of uncoupling proteins and a modulator of the mitochondrial transition pore. Furthermore, recent data indicate that CoQ 10 affects the expression of genes involved in human cell signaling, metabolism and transport, and some of the effects of CoQ10 supplementation may be due to this property. CoQ10 deficiencies are due to autosomal recessive mutations, mitochondrial diseases, aging-related oxidative stress and carcinogenesis processes, and also statin treatment. Many neurodegenerative disorders, diabetes, cancer, and muscular and cardiovascular diseases have been associated with low CoQ10 levels as well as different ataxias and encephalomyopathies. CoQ10 treatment does not cause serious adverse effects in humans and new formulations have been developed that increase CoQ10 absorption and tissue distribution. Oral administration of CoQ10 is a frequent antioxidant strategy in many diseases that may provide a significant symptomatic benefit.
Identifiersdoi: 10.1159/000360101
issn: 1661-8769
e-issn: 1661-8777
Appears in Collections:(CABD) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.